Objective To validate a novel proxy gene-by-environment (G×E) Mendelian randomization (MR) 21 approach by replicating the previously established effect of maternal smoking heaviness in 22 pregnancy on offspring birthweight, and then use GxE MR to investigate the effect of smoking 23 heaviness in pregnancy on offspring health outcomes in later life and grandchild's birthweight. 24
offspring. For grandchild's birthweight, the effect of grandmother's smoking heaviness in pregnancy 44 may be modulated by maternal smoking status in pregnancy. 45 (word count: 300) 46
Introduction 60
The developmental origins of health and disease hypothesis proposes that early life experiences, 61 including those in utero, can have long-term health effects, and maternal pregnancy exposures are 62 important to long-term health of offspring (1) . Heavier maternal smoking in pregnancy is known to 63 be causally associated with lower offspring birthweight (2-6), but its other effects in offspring are 64 less clear. Multivariable regression in observational data showed that heavier maternal smoking 65 during pregnancy was associated with offspring being shorter (7) and more overweight/obese (8, 9), 66 and having higher blood pressure (10), but had mixed associations with age at menarche (11), 67 respiratory (12), cognitive (13), and mental health (14) . Heavier maternal smoking in pregnancy has 68 also been associated with higher grandchild's birthweight in certain subpopulations (15) (16) (17) . It is 69 unclear whether these associations reflect a causal effect of maternal smoking in pregnancy, as they 70 may be due to residual confounding. Some studies have assessed this using paternal smoking as a 71 'negative control' since an effect via uterine environment would be observed in mothers but not 72 fathers, such that similar-magnitude associations would indicate confounding via shared familial, 73 social, environmental and genetic factors (2, 5, 18). Negative control studies suggest little evidence 74 of a causal effect on offspring body mass index (BMI) (2, 5, 8), blood pressure (19, 20) and 75
depression (21). 76
Mendelian randomization (MR) provides an alternative way to explore this question by using single 77 nucleotide polymorphisms (SNPs) as instrumental variables (IVs) for an exposure of interest. MR is 78 less prone to confounding as germline genetic variants are randomly allocated at meiosis and not 79 influenced by subsequent socioeconomic and health behaviours (22, 23) . MR has been applied in a 80 gene-by-environment (G×E) framework (24, 25) , which requires variation in the strength of the 81 gene-exposure association across strata of another factor. If there is a causal effect of the IV on the 82 outcome via the exposure of interest, then we would expect the association of the IV with the 83 outcome to vary in proportion to the gene-exposure association. The rs1051730/rs16969968 84 (CHRNA5) SNPs, previously robustly associated with smoking heaviness amongst smokers (26), have 85 been widely used as IVs for smoking heaviness in GxE MR studies (3, 27-29). A causal effect of the 86 smoking heaviness IV on an outcome should be seen amongst ever but not amongst never smokers 87 if the effect is via smoking heaviness rather than other pathways (24, 25) . G×E MR has also been 88 used to assess cross-generational causal effects. A smoking heaviness IV has been associated with 89 lower offspring birthweight amongst mothers who smoked in pregnancy but not amongst mothers 90 who did not smoke in pregnancy, suggesting the genetic instrument affects birthweight through 91 maternal smoking (3). 92
It is usually difficult to investigate transgenerational associations due to a lack of data across the 93 generations of interest. Thus, previous work has sought to test transgenerational associations using 94 available traits as proxies for unmeasured traits of interest. A Norwegian cohort aimed to examine 95 whether women's smoking in adulthood was related to their mothers' smoking habits (that were not 96 recorded) and hence used maternal smoking-related mortality as a proxy (30). Recently, a case-97 control by proxy approach has been proposed (31). Participants' genotypes were used to proxy 98 unavailable parental genotypes, and their associations were tested against parental diagnosis of 99
Alzheimer's disease in UK Biobank (31), since Alzheimer's disease was much more prevalent in the 100 parents than the participants (aged between 40 and 69 at baseline in 2006-2010 (32)). Our study 101 aimed to demonstrate how an analogous approach can be used within a G×E MR framework to test 102 maternal-offspring effects when maternal genotype is not available, using offspring genotype as a 103 proxy for the maternal genotype. First, we performed a proof of principle analysis to demonstrate 104 this approach, testing the previously established finding that maternal smoking in pregnancy leads to 105 lower offspring birthweight. Second, we tested for causal effects of maternal smoking on offspring 106 later life outcomes. Finally, we tested for a causal effect of grandmother's smoking on grandchild's 107
birthweight. 108
Methods 109
Study population 110
Our study was conducted using UK Biobank, a population-based cohort of more than 500,000 men 111 and women in the UK. This study collected a large and diverse range of data from physical measures, 112 questionnaires and hospital episode statistics (32). Of 463,013 participants of European descent with 113 genetic data passing initial quality control (i.e. genetic sex same as reported sex, XX or XY in sex 114 chromosome and no outliers in heterozygosity and missing rates) (33), 289,684 participants (54% 115 women) of white British descent were eligible for inclusion in our analyses (Supplementary Figure 1) . 116
We refer to the UK Biobank participants as generation one (G1), and their parents and offspring as 117 G0 and G2, respectively. 118
Genetic IV for maternal smoking 119
The rs16969968 SNP located in CHRNA5 has been robustly associated with smoking heaviness (26). 120
Ideally, we would use the maternal rs16969968 as an IV for the heaviness of maternal smoking, but 121 in UK Biobank parental genetic data are not available. Hence, we used rs16969968 of the UK Biobank 122 participants as a proxy for that of their mothers', coded as the number of smoking heaviness 123 increasing alleles. 124
Smoking phenotypes 125
We used participants' answers to the question "Did your mother smoke regularly around the time 126 when you were born?" as a proxy for G0 smoking during pregnancy. Participants were also asked to 127 report their smoking status (current/former/never). We derived a binary ever versus never measure 128 of smoking status by combining current and former smokers. For female participants with at least 129 one live birth, we derived a measure denoting whether they smoked during the pregnancy of their 130 first child (see Supplementary Methods). 131
Outcomes in participants (G1) 132
We used baseline data measured at the UK Biobank initial assessment center. Anthropometric traits 133 included participants' birthweight (kg, self-reported), standing height (cm) and BMI (kg/m 2 , 134 constructed from standing height and weight). To assess lung function, forced vital capacity (L) and 135 forced expiratory volume in 1-second (L) were measured by spirometry. Participants reported 136 whether they had had asthma via the question "Has a doctor ever told you that you have had any of 137 the following conditions?" (with an option of asthma) (34) . Systolic and diastolic blood pressure 138 (mmHg) were measured twice using a digital monitor or a manual sphygmomanometer if the digital 139 monitor could not be employed, and we took the average of the two readings. Female participants 140
reported their age at menarche. We derived years of education based on qualifications achieved by 141 participants, as described previously (35). We included follow-up data of a subset of participants to 142 define intelligence and depression/anxiety. Fluid intelligence score was generated as an unweighted 143 sum of the number of correct answers given to 13 questions, and we used the earliest score if we 144 had data at multiple time points (36). We defined depression/anxiety cases as participants that 145 either answered "Yes" to "Have you ever seen a general practitioner (GP) for nerves, anxiety, tension 146 or depression?" or "Have you ever seen a psychiatrist for nerves, anxiety, tension or depression?", 147 or had hospital episode coded using ICD-10 (37). Happiness was assessed via a question -"In general 148 how happy are you?", with six categories ranging from "extremely happy" to "extremely unhappy". 149
Outcomes in participants' offspring (G2) 150
The female participants with at least one live birth were asked to report their first child's 151 birthweight. Male participants were not asked to report the birthweight of their offspring. 152
Statistical analyses 153

Proof of principle analysis: testing the causal effect of maternal (G0) smoking heaviness in pregnancy 154 on participants' (G1) birthweight 155
In this proof of principle analysis, we seek to replicate the finding, previously established using GxE 156 MR and many other methods (6), that heavier maternal smoking causes lower offspring birthweight. 157
We use our proxy GxE approach, where participants' (G1) genotype is used as a proxy for their 158 mothers' (G0) genotype. To assess whether rs16969968 affects participants' birthweight via G0 159 smoking in pregnancy, we stratified our G1 sample by G0 smoking status during pregnancy, and then 160 tested the associations of rs16969968 with birthweight in each stratum using multivariable linear 161 regression. Since birth precedes smoking initiation, participants' genotype cannot affect birthweight 162 through their own smoking heaviness, which means we do not need to consider smoking status of 163 participants ( Figure 1A ). We included participants' sex as a covariate to reduce variation in their 164 birthweight and the first ten principal components to control for population stratification. We 165 assumed an additive genetic effect and identified the strength of interaction between strata using 166
Cochran's Q test for heterogeneity. 167
Testing for causal effects of G0 smoking in pregnancy on G1 later life outcomes 168
We use the proxy GxE MR approach to test for causal effects of maternal (G0) smoking heaviness on 169 offspring (G1) height, BMI, lung function, asthma, blood pressure, age at menarche, education, 170 intelligence, depression/anxiety and happiness. In contrast to our proof of principle example where 171 participants smoking in adulthood cannot influence their birthweight, participants' rs16969968 172 could affect these outcomes via both maternal (G0) and participants' (G1) smoking heaviness (Figure  173 1B). To assess whether rs16969968 may affect these outcomes via maternal versus participants' 174 smoking, we stratified on both maternal and participants' smoking status. In each stratum, we 175 examined associations of rs16969968 with height, BMI, lung function, blood pressure, age at 176 menarche, education and intelligence using linear regression, asthma and depression/anxiety using 177 logistic regression, and happiness using ordinal logistic regression. We included participants' age at 178 baseline, sex and the first ten genetic principal components as covariates. 179
Height and age at menarche manifest around the time of puberty such that participants' own 180 smoking can only affect these if they started smoking before these outcomes are determined. We 181 conducted sensitivity analyses for these outcomes stratifying G1 participants according to whether 182 they were ever smokers before achieving their adulthood height (assuming age at 17 for men and 15 183 for women (38)) or their age at menarche. 184
Testing for causal effects of G0 smoking in pregnancy on grandchild's (G2) birthweight 185
To test for a causal effect of participants mothers' smoking on birthweight of participants' offspring, 186 we stratified G1 women based on their own and their mothers' smoking status during pregnancy, as 187 rs16969968 could affect G2 birthweight through both G0 and G1 smoking heaviness ( Figure 1C) . 188
Within each stratum, we assessed associations of rs16969968 with G2 birthweight using linear 189 regression, adjusting for the first ten genetic principal components. We estimated the strength of 190 interaction between G0 smokers and G0 non-smokers within each G1 stratum. We also calculated a 191 difference (39) in those associations between G0 smokers and G0 non-smokers within each G1 192 stratum, and estimated the strength of interaction between two differences to investigate whether 193 G1 smoking status modulates the effect of rs16969968 on G2 birthweight. ) higher odds that female participants were a smoker 210 (versus non-smoker) in their own pregnancy. We found little evidence of an association between 211 rs16969968 and potential confounders, with small associations for participants' age and years of 212 education in some strata (Supplementary Table 2 ). 213
Our proof of principle analysis found that, amongst participants whose mothers smoked in 214 pregnancy, each additional smoking-increasing allele was associated with a 0.018kg lower 215 birthweight (95% CI: -0.026, -0.009) after adjustment for covariates (Figure 2 ). Amongst participants 216 whose mothers did not smoke in pregnancy, we found little evidence for an association of 217 rs16969968 with birthweight (-0.002kg [95% CI: -0.008, 0.003]), and we observed heterogeneity 218 between these associations (interaction P-value = 0.004). 219 Figure 3 showed estimates of rs16969968 on the 12 outcomes in the UK Biobank participants. 220
Overall, within each stratum, the estimates were broadly consistent between those whose mothers 221 smoked and those whose mothers did not, except for height among participants who never smoked 222 (all interaction P-values were in Supplementary Table 3) . Each additional smoking-increasing allele 223 was associated with a 0.115cm lower height (95% CI: -0.200, -0.030) among never smokers whose 224 mothers smoked in pregnancy, but a 0.002cm lower height (95% CI: -0.057, 0.053) among never 225 smokers whose mothers did not smoke in pregnancy (interaction P-value = 0.029). However, this 226 difference was not observed amongst ever smokers ( Figure 3A) . We obtained largely consistent 227 results in sensitivity analyses (Supplementary Figure 3) . 228 Figure 4 showed estimates of rs16969968 on grandchild's birthweight. Among female participantswho did not smoke in pregnancy, each additional smoking-increasing allele was associated with a 230 0.007kg higher grandchild's birthweight difference (95% CI: -0.005, 0.020) between grandmothers 231 who did versus did not smoke in pregnancy. However, this difference was -0.020kg per allele (95% 232 CI: -0.044, 0.003) among female participants who smoked in pregnancy. These two differences were 233 heterogeneous (-0.028kg per allele [95% CI: -0.055, -0.001]; interaction P-value=0.042). 234
The directions of observational estimates were consistent with our MR estimates for both 235 participants' and their child's birthweight. Our observational analyses also found associations of 236 maternal smoking in pregnancy with offspring later life outcomes, where smoking in pregnancy was 237 associated with lower height, higher BMI, poorer lung function, higher risk of asthma, earlier age at 238 menarche, higher blood pressure, and poorer cognitive and mental health (Supplementary Table 4) . 239
Discussion 240
Principle findings and comparison with the literature 241
In this study, we have demonstrated how G×E MR can be used to test transgenerational causal 242 effects of maternal smoking heaviness in pregnancy using participants' genotype as a proxy for their 243 mothers' genotype. Our proof of principle analysis identified an effect of heavier maternal smoking 244 on lower offspring birthweight, consistent with previous studies (2-6). Our MR study also confirmed 245 previously established causal effects of participants' smoking on their own health, where heavier 246 smoking reduced BMI (27) and lead to impaired lung function (42), but found little evidence of an 247 effect on asthma risk (43) or blood pressure (28). 248
Our tests of effects of maternal smoking heaviness on offspring later life health outcomes were not 249 conclusive, given a lack of precision for many of our MR estimates. We found little evidence of an 250 effect on BMI, lung function, asthma, blood pressure, cognition, depression/anxiety or happiness. results for this outcome less comparable. We observed lower offspring adulthood height according 260 to maternal smoking in never smokers but not in ever smokers, which could be a chance finding 261 given we tested multiple outcomes. 262
We found little evidence of an effect of maternal smoking in pregnancy on offspring age at 263 smoking status (of both the participant and participants' mother) suggesting that rs16969968 may 265 have horizontal pleiotropic effects on age at menarche (e.g. via smoking outside of pregnancy). 266
Future MR studies could examine this (25) . 267
Our observational results were consistent with previous observational studies (15) (16) (17) by showing a 268 positive association of grandmother's (G0) smoking in pregnancy with grandchild's (G2) birthweight 269 after adjusting for mother's (G1) smoking in pregnancy. Although our G×E MR was vulnerable to 270 insufficient statistical power, we did find evidence that female G1 smoking in pregnancy modulates 271 the effect of G0 smoking heaviness in pregnancy on G2 birthweight, consistent with previous 272 observational findings (15) (16) (17) . These results highlight the importance of both grandmother's and 273 maternal smoking in pregnancy for fetal growth, which could have implications for public health 274 interventions aiming to reduce the prevalence of low birthweight. 275
Strength of weakness of this study 276
We now discuss some limitations of this work. First, our proxy G×E MR used offspring genotype as a 277 proxy for maternal genotype and offspring rs16969968 contains 50% information from fathers. This 278 may cause regression dilution bias in each stratum, where the measurement error in the SNP biases 279 associations towards the null (48). However, we checked the extent that this might affect our 280 results, by comparing the associations of participant's rs16969968 with their own birthweight versus 281 their child's birthweight for smokers during pregnancy, and found little difference (-0.005kg (95% CI: 282 -0.020, 0.009)) between them. Second, we stratified on smoking status which rs16969968 was 283 weakly associated with. Stratification on colliders (between rs16969968 and outcomes) may bias our 284 MR estimates (see Supplementary Figure 2) (40, 41) . Additionally, we used a highly selected sample 285 related to smoking (49) and had missing data in outcomes. These may also make our MR estimates 286 vulnerable to selection bias (50). However, previous evidence (29, 51) and our genetic associations 287 with measured confounders indicated that these selection effects may not be large enough to have a 288 considerable impact on our MR estimates. Third, rs16969968 predicts life-course smoking heaviness 289 and not just in pregnancy. Women who smoked in pregnancy may also smoke outside of pregnancy. 290 Therefore, the effect of maternal smoking might be via other pathways such as poor oocyte quality 291 for offspring birthweight, or postnatal maternal smoking (e.g. passive smoke exposure) for 292 adulthood outcomes among offspring (52). 293
Fourth, both participants' and their mothers' (G0) smoking status may be misclassified. Participants 294 were asked to report whether their mother smoked around the time of their birth and we used this 295 as our measure of G0 smoking in pregnancy. This means that G0 smokers might have smoked during 296 all their pregnancy, part of their pregnancy or started smoking shortly after giving birth. Effects of 297 smoking heaviness in pregnancy may vary according to the duration and pregnancy period during 298 which a woman smoked. For instance, previous work found that smoking in the first trimester was 299 not associated with lower birthweight in offspring suggesting that later stages may be more 300 important for fetal growth (3, 15). Similarly, participants reported their smoking status at baseline, 301 but this may not reflect their smoking status at an important time point for a given outcome. For, 302 instance, participants' height and age at menarche can only be affected by their own smoking 303 behaviour if they started smoking before achieving adult height or the onset of puberty. We 304 performed sensitivity analyses for height and age at menarche using estimates of participants 305 smoking status before these outcomes. For height, this assumed that men and women achieved 306 their adult height at 17 and 15 years old (38), respectively, as this information was not available in 307 UK Biobank. Fifth, we tested several hypotheses which increases the probability that our identified 308 associations may be due to chance. Finally, our study may lack statistical power due to small sample 309 sizes in strata and the low power of tests for interactions (53). We were unable to account for 310 grandchild's sex in our models assessing the impact of grandmother's smoking in pregnancy since 311 that is unavailable in UK Biobank, which may also reduce our statistical power. MR studies with 312 larger sample sizes and hence greater statistical power are needed to further investigate 313 transgenerational effects of smoking heaviness, together with studies in which both maternal and 314 offspring genotype are known. 315
Conclusion 316 G×E MR demonstrates how offspring genotype can be used to proxy for maternal genotype to 317 investigate causal effects of maternal smoking heaviness in pregnancy when maternal genotype is 318 unavailable. We demonstrated our proxy GxE approach by replicating the previously identified effect 319 of heavier smoking on lower offspring birthweight. We found little evidence of a causal effect of 320 maternal smoking heaviness on offspring's later life outcomes. Finally, we found evidence that the 321 effect of grandmother's smoking in pregnancy on grandchild's birthweight may be modulated by 322 A) Assessing the effect of G0 smoking heaviness on G1 birthweight: We used G1 rs16969968 as a 514 proxy for G0 rs16969968 and stratified on G0 smoking status in pregnancy. There is no backdoor 515 path (54) via G1 smoking heaviness since G1 cannot smoke before they were born. Maternal 516 smoking outside of pregnancy might influence the outcome (52), e.g. via oocyte quality, causing an 517 alternate path between rs16969968 and G1 birthweight (shown as ). 518 B) Assessing the effect of G0 smoking on G1 later life outcomes: Besides the paths described in (A),  519 there is a backdoor path from G1 rs16969968 via G1 life-course smoking heaviness to the outcomes. 520
To estimate the effect of G0 smoking heaviness in pregnancy (shown as ), we need to block 521 this backdoor path by further stratifying on G1 smoking status. 522 C) Assessing the effect of G0 smoking on G2 birthweight: Besides the paths described in (A), there is 523 a backdoor path from G1 rs16969968 via G1 smoking heaviness in pregnancy to the outcomes. To 524 estimate the effect of G0 smoking heaviness in pregnancy (shown as ), we need to block this 525 backdoor path by further stratifying on G1 smoking status in pregnancy. G1 pre-pregnancy smoking 526 might influence G2 birthweight (shown as ). 527
See further DAGs in the Supplementary Figure 2 illustrating potential sources of bias due to 528 conditioning on a collider. 529 outcome per each smoking-heaviness increasing allele of rs16969968. We adjusted for age and sex of participants for outcomes except for menarche, and 541 the first ten principal components for all 12 outcomes. We combined G1 current and former smokers into ever smokers for height, menarche, education, 542 asthma and happiness to enlarge sample sizes given smoking cessation may not have a rapid impact on them. 543
Abbreviations: BMI, body mass index, DBP, diastolic blood pressure; FEV1, forced expiratory volume in 1-second; FVC, forced vital capacity; SBP, systolic 544 blood pressure. 545 non-smokers (green line) with their P-values presented. All women in G1 included G1 smokers, G1 non-smokers and G1 women whose smoking status in 551 pregnancy was missing. 552
